№16 (269) / 2013

E.V. Biryukova, T.B. Danilova
EFFICACY AND SAFETY OF GLYCAEMIC CONTROL USING DIABETON MR: PREREQUISITE FOR SUCCESSFUL PREVENTION OF CHRONIC COMPLICATIONS OF TYPE 2 DIABETES MELLITUS 		14-16
I.A. Kurnikova
METABOLIC SYNDROME IN DIABETIC PATIENTS AND ITS CORRECTION USING THIOCTIC ACID PREPARATIONS 		20-26
N.A. Chernikova 1, M.B. Antsiferov 2
ROLE AND PLACE OF HYPOGLYCEMIA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS 		27-32
E.A. Ushkalova
NEW CLASS OF ANTIDIABETIC DRUGS - SODIUM- GLUCOSE COTRANSPORTER INHIBITORS 		33-36
N.A. Chernikova 1, A.S. Ametov 1, M.B. Antsiferov 2
BASAL INSULIN THERAPY: EXPERIENCE IN CLINICAL PRACTICE 		37-41
M.B. Antsiferov 1; V.S. Pronin 2; T.M. Alekseeva 1, L.G. Dorofeeva 1
EXPERIENCE OF MAINTENANCE OF MOSCOW REGISTER OF PATIENTS WITH ACROMEGALY: POTENTIALS FOR THE SOLUTION OF VARIOUS THERAPEUTIC PROBLEMS 		42-47
M.B. Antsiferov
LONG-TERM SAFETY AND EFFICACY OF INSULIN ASPART IN PATIENTS WITH TYPE 1 DIABETES MELLITUS 		48-51
M.E. Statsenko, M.V. Derevyanchenko
FEATURES OF MANAGEMENT OF HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A VIEW OF CARDIOLOGIST 		52-57
E.V. Biryukova, T.B. Danilova
PHARMACOTHERAPY OF DIABETIC NEUROPATHY: WHAT ELSE EXCEPT GLYCEMIC CONTROL? 		58-63
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS 		64-70
A.S. Ametov, E.A. Tertychnaya
MANAGEMENT OF LIPOTOXICITY IN THE DEBUT OF TYPE 2 DIABETES MELLITUS 		72-77
O.A. Shavlovskaya, MD
FEATURES OF STROKE THERAPY IN DIABETIC PATIENTS 		78-83
N.A. Strebkova
MAIN PRINCIPLES OF TREATMENT OF DIABETES INSIPIDUS IN CHILDREN 		84-87
L.N. Gorobets
GENERAL ISSUES OF DIAGNOSIS AND PREVENTION OF NEUROENDOCRINE DYSFUNCTIONS IN PSYCHIATRIC PATIENTS 		88-91
Yu.E. Poteshkin
THE CASE OF PSEUDOHYPOPARATHYREOSIS IN 33 YEAR-OLD MAN 		92-95

Бионика Медиа